Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map

Producció científica: Contribució a una revistaArticle de revisióRecercaAvaluat per experts

2 Cites (Scopus)


PURPOSE: To identify, describe, and organise currently available evidence regarding systemic oncological treatments (SOTs) (chemotherapy, targeted/biological therapies, and immunotherapy) compared to best supportive care (BSC) for patients with advanced pancreatic cancer (PC).

METHODS: We conducted a scoping review and evidence mapping, adhering to PRISMA-ScR checklist. We searched MEDLINE, EMBASE, Cochrane Library, Epistemonikos, PROSPERO, and for eligible studies. We included systematic reviews (SRs), randomised controlled trials (RCTs), quasi-experimental, and observational studies evaluating SOTs compared to BSC or no treatment in patients with advanced PC. Two independent reviewers performed the screening process and data extraction. We developed evidence maps as an interactive visualization display, including the assessed interventions and outcomes.

RESULTS: Of the 50,601 records obtained from our search, we included 43 studies: 2 SRs, 16 RCTs, 4 quasi-experimental studies, 20 observational studies, and 1 protocol for a quasi-experimental study. Forty-two studies reported survival-related outcomes and most favoured SOTs, while five reported toxicity and most favoured BSC. Other patient-centred outcomes, such as quality of life, were scarcely reported.

CONCLUSIONS: This study highlights the current evidence gaps in studies assessing treatments for patients with advanced PC, mainly the lack of reports of non-survival-related outcomes, pointing out research areas that need further attention to make better recommendations for these patients.

Idioma originalEnglish
Número d’article100
Pàgines (de-a)100
Nombre de pàgines14
RevistaSupportive Care in Cancer
Estat de la publicacióPublicada - 9 de gen. 2023


Navegar pels temes de recerca de 'Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map'. Junts formen un fingerprint únic.

Com citar-ho